William Figg

William Figg is an Adjunct Professor of Medicine at Columbia University’s College of Physicians and Surgeons and serves as Acting Chief and Head of the Molecular Pharmacology Section at the National Cancer Institute’s Center for Cancer Research. He earned a Doctor of Pharmacy from Auburn University, a fellowship in drug development from the University of North Carolina at Chapel Hill, and an MBA from Columbia University and the London Business School. His research focuses on clinical pharmacology, therapeutic drug monitoring, antibody–drug conjugates, and biomarker-guided therapy in prostate cancer, particularly targeting the PI3K/AKT pathway and PTEN deficiency. Recent work includes pharmacokinetic assays for miransertib and atezolizumab dosing personalization. He has received the Therapeutics Frontier Award and delivered the Albert Ebert Memorial Lecture.